Mucopolysaccharidosis type II (MPS II): Evaluate of food intakes in patients on enzyme replacement therapy

被引：0
|
作者：
Oliveira, R. B. [1 ]
Frangipani, B. J. [1 ]
Lauandos, J. R. [1 ]
Micheletti, C. [1 ]
Silveira, M. T. [1 ]
Vertemati, T. [1 ]
Martins, A. M. [1 ]
机构：
[1] CREIM UNIFESP, Sao Paulo, Brazil
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2008年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
397P
引用
收藏
页码：100 / 100
页数：1
相关论文
共 50 条
  • [1] OCULAR MANIFESTATIONS OF MUCOPOLYSACCHARIDOSIS TYPE II (MPS II): RESPONSE TO ENZYME REPLACEMENT THERAPY
    Yaplito-Lee, J.
    Elder, J.
    Delatycki, M.
    Peters, H.
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (03) : 222 - 223
  • [2] Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II
    Higuchi, Takashi
    Shimizu, Hiromi
    Fukuda, Takahiro
    Kawagoe, Shiho
    Matsumoto, Juni
    Shimada, Yohta
    Kobayashi, Hiroshi
    Ida, Hiroyuki
    Ohashi, Toya
    Morimoto, Hideto
    Hirato, Tohru
    Nishino, Katsuya
    Eto, Yoshikatsu
    MOLECULAR GENETICS AND METABOLISM, 2012, 107 (1-2) : 122 - 128
  • [3] Disease course after cessation of enzyme replacement therapy (ERT) in 5 patients with type II mucopolysaccharidosis (MPS II)
    Sivananthan, Siyamini
    Stewart, Catherine
    Finnegan, Niamh
    Santra, Saikat
    Vellodi, Ashok
    Cleary, Maureen
    Chakrapani, Anupam
    MOLECULAR GENETICS AND METABOLISM, 2015, 114 (02) : S107 - S108
  • [4] Enzyme replacement therapy in mucopolysaccharidosis type II
    Castorina, M.
    Antuzzi, D.
    Zampetti, A.
    Ricci, R.
    ACTA PAEDIATRICA, 2008, 97 : 101 - 101
  • [5] Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II
    Wraith, J. Edmond
    ACTA PAEDIATRICA, 2008, 97 : 76 - 78
  • [6] Investigational intrathecal (IT) enzyme replacement therapy for the severe form of Hunter syndrome (mucopolysaccharidosis type II, MPS II)
    Muenzer, Joseph
    Hendriksz, Christian J.
    Stein, Margot B.
    Fan, Zheng
    Kearney, Shauna
    Horton, Johan
    Vijayaraghavan, Suresh
    Perry, Victor
    Santra, Saikat
    Solanki, Guirish A.
    Wang, Nan
    Mascelli, Mary Ann
    Pan, Luying
    Sciarapp, Kenneth
    Barbier, Ann J.
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S79 - S79
  • [7] Update on enzyme replacement therapy in mucopolysaccharidosis type II
    Muenzer, J
    Scarpa, M
    ACTA PAEDIATRICA, 2002, 91 : 81 - 81
  • [8] Growth in patients with mucopolysaccharidosis type II receiving enzyme replacement therapy
    Schulze-Frenking, G.
    Wendt, S.
    Mengel, E.
    Beck, M.
    ACTA PAEDIATRICA, 2008, 97 : 100 - 100
  • [9] Effects of enzyme replacement therapy on growth in patients with mucopolysaccharidosis type II
    Schulze-Frenking, G.
    Jones, Simon A.
    Roberts, J.
    Beck, M.
    Wraith, J. E.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 (01) : 203 - 208
  • [10] Clinical benefit of enzyme replacement therapy (ERT) in mucopolysaccharidosis II (MPS II, Hunter syndrome)
    Muenzer, J.
    Wraith, E.
    Beck, M.
    Giugliani, R.
    Harmatz, P.
    Eng, C. M.
    Vellodi, A.
    Martin, R.
    Ramaswami, U.
    Calikoglu, M.
    Vijayaraghavan, S.
    Puga, A.
    Ulbrich, B.
    Shinawi, M.
    Cleary, M.
    Wendt, S.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 : 28 - 28
12345